Showing results (251-260 of 266) with videos related to

Sort By:
Pageof 27
European Urology|September 16, 2022
B7-H3 as a Therapeutic Target in Advanced Prostate CancerChristina Guo, Ines Figueiredo, Bora Gurel, et al.
Molecular Cancer|March 23, 2022
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancerC E Fletcher, L Deng, F Orafidiya, et al.
European Urology|May 1, 2019
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate CancerAdam Sharp, Jon C Welti, Maryou B K Lambros, et al.
Cancer Research|April 6, 2021
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate CancerAlec Paschalis, Jonathan Welti, Antje J Neeb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate CancerAdam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Elife|August 23, 2017
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancerLaura Cato, Antje Neeb, Adam Sharp, et al.
Cancer Research|November 10, 2021
HER3 Is an Actionable Target in Advanced Prostate CancerVeronica Gil, Susana Miranda, Ruth Riisnaes, et al.
Cancer Discovery|January 12, 2021
Targeting the p300/CBP Axis in Lethal Prostate CancerJonathan Welti, Adam Sharp, Nigel Brooks, et al.
European Urology|November 12, 2020
Advanced Prostate Cancer with ATM Loss: PARP and ATR InhibitorsAntje Neeb, Nicolás Herranz, Sara Arce-Gallego, et al.
The New England Journal of Medicine|May 17, 2018
MRI-Guided Thrombolysis for Stroke with Unknown Time of OnsetGötz Thomalla, Claus Z Simonsen, Florent Boutitie, et al.
Pageof 27